Cas:1391463-17-4 (R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate manufacturer & supplier

We serve Chemical Name:(R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate CAS:1391463-17-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate

Chemical Name:(R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate
CAS.NO:1391463-17-4
Synonyms:(R)-2-(3-fluorophenyl)pyrrolidine (2R,3R)-2,3-dihydroxysuccinate
Molecular Formula:C14H18FNO6
Molecular Weight:315.29400
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:127.09000
Exact Mass:315.11200
LogP:0.45640

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (R)-2-(3-fluorophenyl)pyrrolidine (2R,3R)-2,3-dihydroxysuccinate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-2-(3-fluorophenyl)pyrrolidine (2R,3R)-2,3-dihydroxysuccinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(R)-2-(3-fluorophenyl)pyrrolidine (2R,3R)-2,3-dihydroxysuccinate Use and application,(R)-2-(3-fluorophenyl)pyrrolidine (2R,3R)-2,3-dihydroxysuccinate technical grade,usp/ep/jp grade.


Related News: Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. (R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate manufacturer ��No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,�� said Kristen Devito, Global Director, Catalent Clinical Supply Services. (R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate supplier Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL. (R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate vendor At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity. (R)-2-(3-Fluorophenyl)pyrrolidine L-Tartrate factory For example, an active ingredient to relieve pain is included in a painkiller.